Falling demand spurs the Marlboro makers to consider reuniting
in an all-stock deal
By Jennifer Maloney and Cara Lombardo
This article is being republished as part of our daily
reproduction of WSJ.com articles that also appeared in the U.S.
print edition of The Wall Street Journal (August 28, 2019).
Marlboro makers Philip Morris International Inc. and Altria
Group Inc. are in advanced talks to merge, a potential blockbuster
deal that would reunite two tobacco giants struggling with
shrinking demand.
The two businesses -- which were split apart in 2008 -- hold the
same portfolio of cigarettes, including industry leader Marlboro,
one of the world's best known brands. The products are sold by
Altria in the U.S. and Philip Morris elsewhere. A combination would
create a company with a market value of roughly $200 billion.
Both companies have been struggling with declining cigarette
consumption and new electronic cigarettes such as those made by
Juul Labs Inc., which are stealing away some smokers. Altria
invested $12.8 billion to take a large stake in Juul last year.
The talks were partly sparked by U.S. authorization this year of
a cigarette alternative that Altria and Philip Morris will jointly
start selling in September, according to people familiar with the
matter, and the realization that it could be easier to sell as one
company rather than through an existing distribution deal.
The discussions are also motivated by the risks -- and
opportunities -- that Juul presents for both companies as the
startup expands outside the U.S., the people said.
Philip Morris is the bigger of the two companies both in terms
of revenue and market value. Based on share prices before the
companies disclosed their talks early Tuesday, Philip Morris had a
market capitalization of about $121 billion and Altria sported a
market value of roughly $88 billion.
The two sides are discussing an all-stock deal with no premium
based on where the two companies' shares have been trading
recently, people familiar with the matter said. Philip Morris would
control about 59% of the combined company under the terms currently
being discussed, some of the people said.
The companies are describing it as a merger of equals because
other elements such as the name, board and management team are
expected to be more balanced, including a roughly evenly split
board, some of the people said. Altria Chief Executive Howard
Willard is unlikely to lead the combined company given that he has
limited experience running international businesses, those people
said.
The two sides could reach a deal within weeks, the people
said.
Philip Morris said the companies were discussing an all-stock
merger but could give no assurance that the talks would lead to any
agreement. Altria issued a similar statement.
After initially jumping on the news, shares of Altria fell 4% to
close Tuesday at $45.25. Philip Morris declined 7.8% to $71.70.
The potential combination would bring the industry full circle
from the 2000s, when global players distanced themselves from the
U.S. market amid legal concerns. British American Tobacco PLC
pulled out in 2004, and Altria spun off its overseas business in
2008 as Philip Morris International. But the litigation risks for
cigarette makers in the U.S. have receded since then.
Two years ago, BAT took over full control of Reynolds American
Inc., the second-largest competitor in the U.S. and maker of brands
such as Camel and Newport.
While Philip Morris and Altria's businesses have traditionally
been divided between the U.S. and the rest of the world, those
lines have been blurring in recent years as each company searches
for growth beyond Marlboros. Philip Morris had nearly $30 billion
in annual sales last year, while Altria brought in nearly $20
billion.
Both companies have warned that cigarette shipments were
declining faster than expected, both in the U.S. and other big
markets such as Japan and Russia. Last month, Altria said more
people were using e-cigarettes exclusively than it had expected.
Philip Morris, meanwhile, earlier this year lowered its earnings
forecast for 2019.
Juul, with Altria's backing, has been launched in over a dozen
international markets where it threatens to hurt Philip Morris's
cigarette sales.
Philip Morris and Altria have also forged a partnership on their
own cigarette alternative, a device called IQOS that heats but
doesn't burn tobacco. Philip Morris sells it in Japan, the U.K. and
other markets, while Altria is set to launch the device in the U.S.
in September.
Philip Morris has spent $6 billion since 2008 developing IQOS
and other next-generation products. Philip Morris Chief Executive
André Calantzopoulos has said the company is shifting its focus to
"a smoke-free future" and could someday stop selling traditional
cigarettes.
Altria's Mr. Willard has gambled that investing in Juul, a
startup whose sleek, nicotine-packed vaporizers are popular with
teens, will help the company keep up with a changing market even if
it cannibalizes sales of Marlboros. "Ten years from now the
majority of the tobacco products that are sold could very well be
noncombustible products," he said in an interview earlier this
year.
That would mark a major consumer shift. U.S. sales of
cigarettes, cigars and smoking tobacco were nearly $107 billion
last year, compared with about $15 billion in sales of smokeless
tobacco and vaping products, according to Euromonitor International
estimates, which include web sales. Vaping products such as Juul
made up $5.6 billion of those sales.
Although fewer people are smoking and cigarette shipments are
falling, U.S. tobacco profits have grown steadily as Altria and
Reynolds regularly push up prices. The U.S. generates the most
tobacco profits of any market outside of China, where tobacco is
controlled by the state.
In the U.S., the companies must navigate an overhaul of U.S.
regulatory policy in which the Food and Drug Administration is
pushing to reduce nicotine in cigarettes to nonaddictive levels and
recently proposed putting graphic warning labels on cigarette
packs. At the same time, the agency is trying to combat a surge in
teen vaping.
U.S. regulators and lawmakers have threatened to ban Juul
devices entirely if underage use continues to increase. The San
Francisco company recently opened Juul-branded retail stores in
Seoul and Toronto and is considering a sales launch of its
vaporizers in China as early as September.
Bonnie Herzog, a tobacco analyst at Wells Fargo, said Altria is
attractive to Philip Morris because of its 35% stake in Juul and
the possibility of capturing all profits from IQOS sales in the
U.S. Likewise, she said, Philip Morris could help with Juul's
overseas expansion.
Jefferies analyst Ryan Tomkins called the deal's timing strange
given Juul's regulatory hurdles but said that a merger would make
the IQOS business in the U.S. more efficient while accelerating the
international expansion of Juul through Philip Morris's sprawling
distribution network, which covers 180 markets.
However, cost savings between the two companies would be limited
to corporate spending and better buying power for tobacco leaves,
he said. And a focus on Juul could cannibalize the market for IQOS,
he added.
--Saabira Chaudhuri contributed to this article.
Write to Jennifer Maloney at jennifer.maloney@wsj.com and Cara
Lombardo at cara.lombardo@wsj.com
(END) Dow Jones Newswires
August 28, 2019 02:47 ET (06:47 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Philip Morris (NYSE:PM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Philip Morris (NYSE:PM)
Historical Stock Chart
From Apr 2023 to Apr 2024